Political Reporter Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Political Reporter Online.

Press releases published on September 23, 2026

Dassault Aviation signe un accord de coopération avec l’AED Cluster Portugal
 Gran Tierra Energy Inc. Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Consider Approval of Sale of Colombian and Ecuadorian Businesses
PredictIt Removes Withdrawal Fees and Introduces Simplified Fee Structure
Quebec-Based Defence Company Launches Canada's Integrated Defence Ecosystem Anchored by University of Alberta and $10 Million Lockheed Martin Contribution
L’entreprise de défense québécoise Sentinel Advanced Military Solutions lance l’écosystème de défense intégré du Canada avec le soutien de l’Université de l’Alberta et une contribution de 10 millions $ de Lockheed Martin
BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission
Optery and Carahsoft Partner to Bring Innovative Personal Data Removal to the Public Sector
Following Drone Dominance Program Selection, XTEND Secures Phase III of U.S. SOCOM Modular Kinetic Lethal Drone Program, Adding to New Drone Dominance Program Selection
Fisher House Foundation Awards 500 Scholarships to Military Children
Transaction in Own Shares
PhAST Corp. Receives FDA Clearance for Rapid Antimicrobial Susceptibility Testing Directly From Positive Blood Cultures
Entente Education Canada urges federal government to take steps to improve cash flow and tax fairness for seniors, caregiver support
MariMed Files Definitive Proxy Statement for Special Meeting of Stockholders to Approve Proposed Reverse Stock Split
Norsk Hydro: Invitation to Hydro's third quarter results 2026
Norsk Hydro: Invitasjon til presentasjon av Hydros resultat for tredje kvartal 2026
OSE Immunotherapeutics Announces Presentation of Combi-TED Phase 2 Topline Results of Tedopi® in Non-Small Cell Lung Cancer at the ESMO 2026 Meeting
OSE Immunotherapeutics annonce la présentation des principaux résultats de l'étude de Phase 2 Combi-TED de Tedopi® dans le cancer du poumon non à petites cellules au Congrès 2026 de l’ESMO

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Political Reporter Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.